RU2013105922A - METHOD FOR OBTAINING ANTI-LUTE BLOOD - AlK, METHOD FOR TREATMENT AND PREVENTION OF POST-BIRTH OBSTETRIC AND GYNECOLOGICAL DISEASES IN COWS - Google Patents

METHOD FOR OBTAINING ANTI-LUTE BLOOD - AlK, METHOD FOR TREATMENT AND PREVENTION OF POST-BIRTH OBSTETRIC AND GYNECOLOGICAL DISEASES IN COWS Download PDF

Info

Publication number
RU2013105922A
RU2013105922A RU2013105922/15A RU2013105922A RU2013105922A RU 2013105922 A RU2013105922 A RU 2013105922A RU 2013105922/15 A RU2013105922/15 A RU 2013105922/15A RU 2013105922 A RU2013105922 A RU 2013105922A RU 2013105922 A RU2013105922 A RU 2013105922A
Authority
RU
Russia
Prior art keywords
blood
alk
antiluteal
cows
prevention
Prior art date
Application number
RU2013105922/15A
Other languages
Russian (ru)
Other versions
RU2526203C1 (en
Inventor
Самат Равхатович Юсупов
Фарук Ахмадуллович Сунагатуллин
Original Assignee
Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана" filed Critical Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана"
Priority to RU2013105922/15A priority Critical patent/RU2526203C1/en
Application granted granted Critical
Publication of RU2526203C1 publication Critical patent/RU2526203C1/en
Publication of RU2013105922A publication Critical patent/RU2013105922A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1. Способ получения антилютеальной крови (АлК), отличающийся тем, что используется мерин, которому двукратно с интервалом 14 дней подкожно вводят лютеолизат в дозе по 20 мл, содержащий части желтого тела беременности коров, и через 14 дней после второго введения берут кровь из яремной вены.2. Способ лечения и профилактики персистентного желтого тела, субинволюции матки и послеродовых эндометритов у коров, включающий на фоне общей терапии применение антилютеальной крови (АлК), отличающийся тем, что в качестве лекарственного средства используется антилютеальная кровь (АлК), которую вводят подкожно в области шеи двукратно по 10 мл, с интервалом 6 дней.1. A method for producing antiluteal blood (ALK), characterized in that a gelding is used, which is injected subcutaneously with a 20 ml dose twice a day, containing parts of the corpus luteum of a cow, and 14 days after the second administration, blood is taken from the jugular veins. 2. A method for the treatment and prevention of persistent corpus luteum, subinvolution of the uterus and postpartum endometritis in cows, which includes the use of antiluteal blood (AlK) as part of general therapy, characterized in that antiluteal blood (AlK) is used as a medicine, which is injected subcutaneously in the neck twice 10 ml, with an interval of 6 days.

Claims (2)

1. Способ получения антилютеальной крови (АлК), отличающийся тем, что используется мерин, которому двукратно с интервалом 14 дней подкожно вводят лютеолизат в дозе по 20 мл, содержащий части желтого тела беременности коров, и через 14 дней после второго введения берут кровь из яремной вены.1. A method for producing antiluteal blood (ALK), characterized in that a gelding is used, which is injected subcutaneously with a 20 ml dose twice a day, containing parts of the corpus luteum of a cow, and 14 days after the second administration, blood is taken from the jugular veins. 2. Способ лечения и профилактики персистентного желтого тела, субинволюции матки и послеродовых эндометритов у коров, включающий на фоне общей терапии применение антилютеальной крови (АлК), отличающийся тем, что в качестве лекарственного средства используется антилютеальная кровь (АлК), которую вводят подкожно в области шеи двукратно по 10 мл, с интервалом 6 дней. 2. A method for the treatment and prevention of persistent corpus luteum, subinvolution of the uterus and postpartum endometritis in cows, which includes the use of antiluteal blood (AlK) as part of general therapy, characterized in that antiluteal blood (AlK) is used as a drug, which is administered subcutaneously in the area neck twice in 10 ml, with an interval of 6 days.
RU2013105922/15A 2013-02-12 2013-02-12 Method of production of anti-luteolytic blood - alb, method of treatment and prevention of postpartum obstetric and gynecological diseases in cows RU2526203C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013105922/15A RU2526203C1 (en) 2013-02-12 2013-02-12 Method of production of anti-luteolytic blood - alb, method of treatment and prevention of postpartum obstetric and gynecological diseases in cows

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013105922/15A RU2526203C1 (en) 2013-02-12 2013-02-12 Method of production of anti-luteolytic blood - alb, method of treatment and prevention of postpartum obstetric and gynecological diseases in cows

Publications (2)

Publication Number Publication Date
RU2526203C1 RU2526203C1 (en) 2014-08-20
RU2013105922A true RU2013105922A (en) 2014-08-20

Family

ID=51384204

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013105922/15A RU2526203C1 (en) 2013-02-12 2013-02-12 Method of production of anti-luteolytic blood - alb, method of treatment and prevention of postpartum obstetric and gynecological diseases in cows

Country Status (1)

Country Link
RU (1) RU2526203C1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK366475A (en) * 1974-08-30 1976-03-01 Merck & Co Inc PROCEDURE FOR THE PREPARATION OF ARYLOXY OR ARYLTHIO-CONTAINING SECOPROSTAGLANDINS
RU2294752C1 (en) * 2005-07-29 2007-03-10 ФГОУ ВПО "Белгородская государственная сельскохозяйственная академия" Method for treating cows at persistent ovarian yellow body in case of genital chlamydiosis
CN102100877B (en) * 2011-03-05 2012-09-19 中国农业科学院兰州畜牧与兽药研究所 Medicament for treating ovarian infertility

Also Published As

Publication number Publication date
RU2526203C1 (en) 2014-08-20

Similar Documents

Publication Publication Date Title
MX2017011280A (en) Topical regional neuro-affective therapy with cannabinoids.
EA201101518A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY
EA201691151A1 (en) CONNECTIONS FOR THE TREATMENT OF PATIENTS WITH ROS1-MUTANT CANCER CELLS
MX2021002321A (en) Novel methods.
WO2016090024A3 (en) Combination therapy for treatment of cancer
EA201491427A1 (en) SUBSTITUTED PHENYLIMIDAZOPIRAZOLES AND THEIR APPLICATION
MY193963A (en) Composition for treating joint diseases and kit containing same
BR112017022984A2 (en) device for facilitating the positioning of a catheter to deliver a drug to a spontaneously breathing patient
RU2013105922A (en) METHOD FOR OBTAINING ANTI-LUTE BLOOD - AlK, METHOD FOR TREATMENT AND PREVENTION OF POST-BIRTH OBSTETRIC AND GYNECOLOGICAL DISEASES IN COWS
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
RU2012129115A (en) METHOD FOR TREATING ACUTE POST-PERMANENT ENDOMETRITIS IN COWS
MX2018005298A (en) Dosage regimen for a phosphatidylinositol 3-kinase inhibitor.
RU2011115966A (en) METHOD FOR OBTAINING ANTIPLACENTIAL BLOOD, ITS APPLICATION FOR PREVENTION AND TREATMENT OF POST-BIRTH OBSTETRIC AND GYNECOLOGICAL DISEASES IN COWS
MX2018013474A (en) Carboxylic acids for early childhood application.
RU2013141056A (en) METHOD FOR COMPREHENSIVE THERAPY OF PRE-INVASIVE AND INVASIVE CERVICAL CANCER
MX2016006375A (en) A combination of dosage units for use in the treatment of pre-term labour condition.
Baymishev et al. Metrolek-O medicine use for the correction of dairy cows reproductive function
RU2015103315A (en) METHOD OF THERAPY BLOCKING IN ANIMALS WITH DISEASES OF THE PELVIC ORGANS AND PROVISION OF OBSTETRIC AID IN PATHOLOGICAL BIRTH
WO2016077565A3 (en) Methods for chronic pain management and treatment using hcg
UA118808U (en) METHOD OF TREATMENT OF INCOMPLETE UTERINE PARTITION
ZA202200330B (en) Pharmaceutical composition of imatinib
UA114594U (en) METHOD OF TREATMENT OF PSORIASIS WITH CONCENTRAL ARTERIAL HYPERTENSION
JP2016504361A5 (en)
RU2016148285A (en) METHOD FOR PREVENTION OF POST-BIRTH DISEASES IN COWS
Kowar Liver failure: case report

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160213